{
  "created_at": "Fri Oct 22 17:45:51 +0000 2021",
  "id_str": "1451545132558344193",
  "full_text": "Pfizer and BioNTech released new data showing their vaccine was 90.7% effective at preventing symptomatic Covid-19 in a study of children 5 to 11 years old. The companies said the vaccine was found to be safe and tolerable. https://t.co/ImSB6qLi1E",
  "display_text_range": [
    0,
    247
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/ImSB6qLi1E",
        "expanded_url": "https://on.wsj.com/30LrKkZ",
        "display_url": "on.wsj.com/30LrKkZ",
        "indices": [
          224,
          247
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 27,
  "favorite_count": 99,
  "possibly_sensitive": false,
  "original_created_at": "Fri Oct 22 13:45:02 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "ファイザー社とバイオンテック社は、5歳から11歳の子供を対象とした研究で、同社のワクチンが症状のあるCovid-19の予防に90.7%の効果があったという新しいデータを発表しました。両社は、本ワクチンの安全性と忍容性が確認されたと述べています。https://t.co/ImSB6qLi1E"
    },
    {
      "locale": "zh",
      "full_text": "辉瑞公司和BioNTech发布的新数据显示，在一项针对5至11岁儿童的研究中，他们的疫苗对预防有症状的Covid-19有90.7%的效果。这些公司表示，该疫苗被认为是安全和可容忍的。https://t.co/ImSB6qLi1E"
    },
    {
      "locale": "zh-Hant",
      "full_text": "輝瑞公司和BioNTech發佈的新數據顯示，在一項針對5至11歲兒童的研究中，他們的疫苗對預防有症狀的Covid-19有90.7%的效果。這些公司表示，該疫苗被認爲是安全和可容忍的。https://t.co/ImSB6qLi1E"
    }
  ]
}